Back to Search Start Over

Radiosynthesis of O-(1-[ 18 F]fluoropropan-2-yl)-O-(4-nitrophenyl)methylphosphonate: A novel PET tracer surrogate of sarin.

Authors :
Hayes TR
Thompson CM
Blecha JE
Gerdes JM
VanBrocklin HF
Source :
Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2018 Dec; Vol. 61 (14), pp. 1089-1094. Date of Electronic Publication: 2018 Nov 04.
Publication Year :
2018

Abstract

O-(1-Fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate is a reactive organophosphate ester (OP) developed as a surrogate of the chemical warfare agent sarin that forms a similar covalent adduct at the active site serine of acetylcholinesterase. The radiolabeled O-(1-[ <superscript>18</superscript> F]fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate ([ <superscript>18</superscript> F] fluorosarin surrogate) has not been previously prepared. In this paper, we report the first radiosynthesis of this tracer from the reaction of bis-(4-nitrophenyl) methylphosphonate with 1-[ <superscript>18</superscript> F]fluoro-2-propanol in the presence of DBU. The 1-[ <superscript>18</superscript> F]fluoro-2-propanol was prepared by reaction of propylene sulfite with Kryptofix 2.2.2 and [ <superscript>18</superscript> F] fluoride ion. The desired tracer O-(1-[ <superscript>18</superscript> F]fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate was obtained in a >98% radiochemical purity with a 2.4% ± 0.6% yield (n = 5, 65 minutes from start of synthesis) based on starting [ <superscript>18</superscript> F] fluoride ion and a molar activity of 49.9 GBq/μmol (1.349 ± 0.329 Ci/μmol, n = 3). This new facile radiosynthesis routinely affords sufficient quantities of [ <superscript>18</superscript> F] fluorosarin surrogate in high radiochemical purity, which will further enable the tracer development as a novel radiolabeled OP acetylcholinesterase inhibitor for assessment of OP modes of action with PET imaging in vivo.<br /> (© 2018 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1099-1344
Volume :
61
Issue :
14
Database :
MEDLINE
Journal :
Journal of labelled compounds & radiopharmaceuticals
Publication Type :
Academic Journal
Accession number :
30347484
Full Text :
https://doi.org/10.1002/jlcr.3688